Ipilimumab Drug Interactions
Currently displaying 130 drugs known to have a moderate interaction with ipilimumab.
- 27 major drug interactions
- 130 moderate drug interactions
Moderate interactions with ipilimumab
Note: Showing generic names only.
A
- adalimumab
- ado-trastuzumab emtansine
- amiodarone
- asparaginase erwinia chrysanthemi
- asparaginase escherichia coli
- atorvastatin
- auranofin
- aurothioglucose
B
C
- cabazitaxel
- calaspargase pegol
- cannabidiol
- carboplatin
- carfilzomib
- cerivastatin
- certolizumab
- chloramphenicol ophthalmic
- chloramphenicol otic
- chloroquine
- cisplatin
- clofarabine
- colchicine
- cortisone
- crizotinib
D
E
- efavirenz
- efgartigimod alfa
- elotuzumab
- elranatamab
- enfortumab vedotin
- epirubicin
- eribulin
- etanercept
- ethambutol
- ethionamide
- etoposide
- etranacogene dezaparvovec
- etravirine
F
G
H
I
- idelalisib
- infliximab
- interferon alfa-2a
- interferon alfa-2b
- interferon alfa-n1
- interferon alfacon-1
- interferon beta-1a
- interferon beta-1b
- iodoquinol
- isoniazid
- ixabepilone
- ixazomib
L
M
N
O
P
- paclitaxel
- paclitaxel protein-bound
- pegaspargase
- peginterferon alfa-2a
- peginterferon alfa-2b
- peginterferon beta-1a
- pitavastatin
- polatuzumab vedotin
- pomalidomide
- ponatinib
- pravastatin
- prednisolone
- prednisone
R
S
T
- talquetamab
- tarlatamab
- teclistamab
- telbivudine
- teniposide
- thalidomide
- thioguanine
- tinidazole
- tisotumab vedotin
- tocilizumab
- trabectedin
- triamcinolone
V
Z
Ipilimumab disease interactions
There are 10 disease interactions with ipilimumab which include:
- colitis
- dermatitis
- endocrinopathies
- hepatitis
- HSCT
- immune system disorder
- ocular disease
- hepatic impairment
- organ transplant
- pneumonitis
More about ipilimumab
- ipilimumab consumer information
- Check interactions
- Compare alternatives
- Reviews (4)
- Side effects
- Dosage information
- During pregnancy
- Drug class: anti-CTLA-4 monoclonal antibodies
- Breastfeeding
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.